UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer

Clinical cancer research, 2023-08, Vol.29 (15), p.2767-2773

2023

Volltextzugriff (PDF)

Visual Representations of Risk Enhance Long-Term Retention of Risk Information: A Randomized Trial

Medical decision making, 2019-02, Vol.39 (2), p.100-107

2019

Volltextzugriff (PDF)

Transactivation of the estrogen receptor promoter by BRCA1

Cancer cell international, 2017-03, Vol.17 (1), p.33-33, Article 33

2017

Volltextzugriff (PDF)

Plasma DNA as a “liquid biopsy” incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer

Breast cancer research and treatment, 2020-08, Vol.182 (3), p.665-677

2020

Volltextzugriff (PDF)

Consequences of altered TGF-β expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects

Oncogene, 2002-01, Vol.21 (1), p.108-118

2002

Volltextzugriff (PDF)

NSABP C-14: CORRECT-MRD II—Second colorectal cancer clinical validation study to predict recurrence using a circulating tumor DNA assay to detect minimal residual disease

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS284-TPS284

2023

Volltextzugriff (PDF)

Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers

Oncogene, 2002-10, Vol.21 (46), p.7034-7041

2002

Volltextzugriff (PDF)

BRCA1 splice variants exhibit overlapping and distinct transcriptional transactivation activities

Journal of cellular biochemistry, 2003-05, Vol.89 (1), p.120-132

2003

Volltextzugriff (PDF)

Glutathione metabolism as a determinant of therapeutic efficacy: a review

Cancer research (Chicago, Ill.), 1984-10, Vol.44 (10), p.4224-4232

1984

Volltextzugriff (PDF)

Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer

Clinical cancer research, 2023-05

2023

Volltextzugriff (PDF)

The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes

The New England journal of medicine, 1982-12, Vol.307 (26), p.1593

1982

Volltextzugriff (PDF)

Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences

The Journal of biological chemistry, 1993-04, Vol.268 (12), p.8881-8887

1993

Volltextzugriff (PDF)

Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells : evidence for both common and distinct activities of wildtype and mutant forms

Oncogene, 2000-12, Vol.19 (54), p.6351-6360

2000

Volltextzugriff (PDF)

Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells

Cancer research (Chicago, Ill.), 1996-10, Vol.56 (20), p.4578-4581

1996

Volltextzugriff (PDF)

Altered Metabolic and Adhesive Properties and Increased Tumorigenesis Associated with Increased Expression of Transforming Growth Factor β1

The Journal of cell biology, 1992-08, Vol.118 (3), p.715-726

1992

Volltextzugriff (PDF)

Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-β3

Cancer research (Chicago, Ill.), 1999-05, Vol.59 (10), p.2292-2296

1999

Volltextzugriff (PDF)

Inhibition of Translation of Transforming Growth Factor-β3 mRNA by Its 5′ Untranslated Region

Molecular and cellular biology, 1991-09, Vol.11 (9), p.4306-4313

1991

Volltextzugriff (PDF)

Consequences of altered TGF-[beta] expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects

Oncogene, 2002-01, Vol.21 (1), p.108

2002

Volltextzugriff (PDF)

Human transforming growth factor-β3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-β1 and -β2

Molecular endocrinology (Baltimore, Md.), 1989, Vol.3 (12), p.1977-1986

1989

Volltextzugriff (PDF)

Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β

American journal of obstetrics and gynecology, 1992-02, Vol.166 (2), p.676-684

1992

Volltextzugriff (PDF)

Response: More About: Multifactorial Analysis of DifferencesBetween Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2Mutations

JNCI : Journal of the National Cancer Institute, 1999-08, Vol.91 (16), p.1422-1422

1999

Volltextzugriff (PDF)

Enhanced translational efficiency of a novel transforming growth factor β3 mRNA in human breast cancer cells

Molecular and cellular biology, 1994-01, Vol.14 (1), p.619-628

1994

Volltextzugriff (PDF)

Re: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

JNCI : Journal of the National Cancer Institute, 1999-01, Vol.91 (1), p.90-91

1999

Volltextzugriff (PDF)

Therapeutic implications of the TGF-beta system

Journal of mammary gland biology and neoplasia, 1996-10, Vol.1 (4), p.391-397

Arrick, B A

1996

Volltextzugriff (PDF)

Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor (Beta)1

The Journal of cell biology, 1992-08, Vol.118 (3), p.715

1992

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Sprache

Englisch
(33)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(15)
Science & Technology
(15)
Biological And Medical Sciences
(14)
Life Sciences & Biomedicine
(14)
Female
(12)
Fundamental And Applied Biological Sciences. Psychology
(9)
Tumors
(9)
Breast Cancer
(8)
Oncology
(8)
Breast Neoplasms - Genetics
(6)
Medical Sciences
(6)
Molecular And Cellular Biology
(6)
Biochemistry & Molecular Biology
(5)
Breast Neoplasms - Pathology
(5)
Cell Biology
(5)
Brca1
(4)
Gynecology. Andrology. Obstetrics
(4)
Mutation
(4)
Transfection
(4)
Alternative Splicing
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer

Visual Representations of Risk Enhance Long-Term Retention of Risk Information: A Randomized Trial

Transactivation of the estrogen receptor promoter by BRCA1

Plasma DNA as a “liquid biopsy” incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer

Consequences of altered TGF-β expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects

NSABP C-14: CORRECT-MRD II—Second colorectal cancer clinical validation study to predict recurrence using a circulating tumor DNA assay to detect minimal residual disease

Increased CpG methylation of the estrogen receptor gene in BRCA1-linked estrogen receptor-negative breast cancers

BRCA1 splice variants exhibit overlapping and distinct transcriptional transactivation activities

Glutathione metabolism as a determinant of therapeutic efficacy: a review

Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer

The cutaneous infiltrates of leprosy: cellular characteristics and the predominant T-cell phenotypes

Association of heterogeneous nuclear ribonucleoprotein A1 and C proteins with reiterated AUUUA sequences

Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells : evidence for both common and distinct activities of wildtype and mutant forms

Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells

Altered Metabolic and Adhesive Properties and Increased Tumorigenesis Associated with Increased Expression of Transforming Growth Factor β1

Methylation of CpGs as a determinant of transcriptional activation at alternative promoters for transforming growth factor-β3

Inhibition of Translation of Transforming Growth Factor-β3 mRNA by Its 5′ Untranslated Region

Consequences of altered TGF-[beta] expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects

Human transforming growth factor-β3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-β1 and -β2

Regulation of growth of normal ovarian epithelial cells and ovarian cancer cell lines by transforming growth factor-β

Response: More About: Multifactorial Analysis of DifferencesBetween Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2Mutations

Enhanced translational efficiency of a novel transforming growth factor β3 mRNA in human breast cancer cells

Re: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

Therapeutic implications of the TGF-beta system

Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor (Beta)1

Suchergebnisse filtern